Last Price | 7.17 | Max Price | 9.75 |
Min Price | 5.51 | 1 Year return | -25.47 |
Sector | Health Care | Subsector | Biotechnology |
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 267 | 136,070 | 0.20 % |
2020 | 203 | 153,065 | 0.13 % |
2021 | 227 | 227,669 | 0.10 % |
2022 | 250 | 260,393 | 0.10 % |
2023 | 291 | 215,054 | 0.14 % |
No Records Found
No Records Found
No Records Found
Over the period from December 2015 till December 2016 the stock lost around 5 percent. Over the past 5 years the stock rose a massive 675 percent. Mimedx Group Inc's revenues between 2011 and 2015 were very fluctuating and moved between 27,05 million dollars and 187,3 million dollars. Mimedx Group Inc's net incomes between 2011 and 2015 were very volatile through the time and moved between -10,19 million dollars and 29,45 million dollars.
Mimedx Group Inc's core business is the software sector. Over the past 10 years the global software & services companies gained around 70 percent. Measured since 2011 the sector is 68 percent higher and over the past 12 months (December 2015-2016) there is a plus of 70 percent.
Over the past 5 years the American company paid out dividends.
At the end of 2015 the software & services company's balance sheet equaled 135,91 million dollars. Last year the total debt of the company was 27,92 million dollars. This equals around 20,54 percent of the total balance sheet. The American company's price/earnings-ratio was 41. So the market valued the stock at 41 times the 2015' earnings per share. We could say that based on it's price/earnings-ratio and dividend yield the American stock can be seen as a growth stock.
At the end of 2015 the market capitalization (the number of shares outstanding multiplied by the stock price) of the software & services company equaled around 943,83 million dollars. At the end of 2015 the American company had around 105,93 million stocks listed.
All Mimedx Group Inc's annual reports can be found here. More information about Mimedx Group Inc can be found it's website. .
Results |
2021
|
2022
|
2023
|
2024
|
2025
|
---|---|---|---|---|---|
Revenue |
|
|
|
|
|
Costs |
|
|
|
|
|
Profit |
|
|
|
|
|
Margin of profit |
|
|
|
|
|
ROI |
|
|
|
|
|
Balance |
2021
|
2022
|
2023
|
2024
|
2025
|
---|---|---|---|---|---|
Equity |
|
|
|
|
|
Debt |
|
|
|
|
|
Total assets |
|
|
|
|
|
Solvency |
|
|
|
|
|
Cash |
|
|
|
|
|
Cashflow |
|
|
|
|
|
Employees |
|
|
|
|
|
Revenue per employee |
|
|
|
|
|
Cashflow / Debt |
|
|
|
|
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
8.86
|
12.61
|
1.79
|
7.58
|
9.08
|
Eps |
0.0
|
0.46
|
-0.25
|
-0.21
|
-0.63
|
Price/earnings-ratio |
0.0
|
27.41
|
-7.16
|
-36.10
|
-11.38
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
1.15
|
0.56
|
0.40
|
0.28
|
0.67
|
Market to book |
0.13
|
0.04
|
0.22
|
0.04
|
0.09
|
Cashflow per stock |
0.21
|
0.48
|
0.29
|
-0.32
|
-0.22
|
Stocks |
110
|
109
|
109
|
111
|
111
|
Market Cap |
973.38
|
1.378.87
|
195.29
|
840.01
|
795.37
|
Date
|
Price
|
---|---|
21 Aug 2025
|
7.17
|
15 Aug 2025
|
7.15
|
07 Aug 2025
|
7.24
|
23 Jul 2025
|
6.76
|
18 Jul 2025
|
6.42
|
17 Jul 2025
|
6.72
|
16 Jul 2025
|
6.71
|
15 Jul 2025
|
6.33
|
14 Jul 2025
|
6.80
|
11 Jul 2025
|
6.66
|
10 Jul 2025
|
6.78
|
09 Jul 2025
|
6.96
|
08 Jul 2025
|
7.00
|
07 Jul 2025
|
6.48
|
03 Jul 2025
|
6.34
|
02 Jul 2025
|
6.23
|
01 Jul 2025
|
6.22
|
30 Jun 2025
|
6.11
|
27 Jun 2025
|
5.94
|
26 Jun 2025
|
5.94
|
25 Jun 2025
|
5.96
|
24 Jun 2025
|
5.96
|
23 Jun 2025
|
5.94
|
20 Jun 2025
|
5.81
|
18 Jun 2025
|
5.90
|
17 Jun 2025
|
5.85
|
16 Jun 2025
|
5.99
|
13 Jun 2025
|
6.04
|
12 Jun 2025
|
6.12
|
11 Jun 2025
|
6.42
|